BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24199985)

  • 1. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
    León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
    J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
    D'Cruz OJ; Dong Y; Uckun FM
    Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyto- and genotoxicity of a vanadyl(IV) complex with oxodiacetate in human colon adenocarcinoma (Caco-2) cells: potential use in cancer therapy.
    Di Virgilio AL; Rivadeneira J; Muglia CI; Reigosa MA; Butenko N; Cavaco I; Etcheverry SB
    Biometals; 2011 Dec; 24(6):1153-68. PubMed ID: 21755303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
    Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
    Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
    Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
    J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
    Cheng YF; Lu XM; Wang G
    Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization; DNA binding and antitumor activity of ruthenium(II) polypyridyl complexes.
    Srishailam A; Gabra NM; Kumar YP; Reddy KL; Devi CS; Anil Kumar D; Singh SS; Satyanarayana S
    J Photochem Photobiol B; 2014 Dec; 141():47-58. PubMed ID: 25318017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of a vanadyl(IV) complex with a multidentate oxygen donor in osteoblast cell lines in culture.
    Rivadeneira J; Di Virgilio AL; Barrio DA; Muglia CI; Bruzzone L; Etcheverry SB
    Med Chem; 2010 Jan; 6(1):9-23. PubMed ID: 20402656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity.
    Jaividhya P; Dhivya R; Akbarsha MA; Palaniandavar M
    J Inorg Biochem; 2012 Sep; 114():94-105. PubMed ID: 22841366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
    León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
    Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
    Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
    J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium (IV) complexes with substituted isoniazid.
    Liao X; Lu J; Ying P; Zhao P; Bai Y; Li W; Liu M
    J Biol Inorg Chem; 2013 Dec; 18(8):975-84. PubMed ID: 24077688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First- and second-generation quinolone antibacterial drugs interacting with zinc(II): structure and biological perspectives.
    Tarushi A; Lafazanis K; Kljun J; Turel I; Pantazaki AA; Psomas G; Kessissoglou DP
    J Inorg Biochem; 2013 Apr; 121():53-65. PubMed ID: 23353082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, cellular uptake, apopotosis, cytotoxicity, cell cycle arrest, interaction with DNA and antioxidant activity of ruthenium(II) complexes.
    Huang HL; Li ZZ; Liang ZH; Yao JH; Liu YJ
    Eur J Med Chem; 2011 Aug; 46(8):3282-90. PubMed ID: 21570748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.
    León IE; Di Virgilio AL; Barrio DA; Arrambide G; Gambino D; Etcheverry SB
    Metallomics; 2012 Dec; 4(12):1287-96. PubMed ID: 23073485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
    Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
    Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
    Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
    Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new oxidovanadium(IV) complex of oxodiacetic acid and dppz: spectroscopic and DFT study. Antitumor action on MG-63 human osteosarcoma cell line.
    León IE; Parajón-Costa BS; Franca CA; Etcheverry SB; Baran EJ
    Biol Trace Elem Res; 2015 Apr; 164(2):198-204. PubMed ID: 25534289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.